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Background: Malignant cerebral infarction is a well-recognized disease, comprising 10-15% of all cases with
cerebral infarction and causing herniation and death in 80% of cases. In this study, we compare the effects of
decompressive craniectomy versus conventional medical treatment on mortality rate and functional and neurological
outcome in patients with malignant MCA infarction.
Methods: We performed a prospective case–control study on 60 patients younger than 80years of age suffering
malignant MCA cerebral infarction. The case group underwent decompressive craniectomy in addition to routine
aggressive medical care; while the control group received routine medical treatment. Patient outcome was assessed
using Glasgow outcome scale and modified Rankin scale within three months of follow-up. The data were analyzed by
SPSS version 16.0 software using Chi Square, One-way ANOVA and Mann–Whitney tests.
Results: There were 27 male and 33 female patients with a mean age of 60.6 years (SD = 12.3). Glasgow outcome scale
score averaged 2.93 in the surgical versus 1.53 in the medical group; this difference was significant (p = 0.001).
Outcome in modified Rankin scale was also significantly lower in the surgical (3.27) versus medical (5.27) group
(p < 0.001). Surgery could decrease the mortality rate about 47%.
Conclusion: In this study, decompressive craniectomy could decrease mortality rate, and improve neurological and
functional outcome, and decrease long-term disability in patients with malignant MCA infarction.
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Malignant supratentorial infarction of the brain is a
well-recognized entity, comprising 10-15% of all cases
with cerebral infarction. It causes severe edema, in-
creased focal and generalized intracranial pressure, and
finally results in transtentorial or uncal herniation in ap-
proximately 80% of individuals (Holtkamp et al. 2001;
Staykov & Gupta 2011; van der Worp & Kappelle 2011).
The optimal management of these patients has been al-
ways a challenge. Decompressive craniectomy (DC) has
been used for many years as an option but not a standard;* Correspondence: ali.razmkon@gmail.com
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reproduction in any medium, provided the origwhile many studies have shown its efficacy in decreasing
mortality rates from 80% to 30% (Aarabi et al. 2006;
Spagnuolo et al. 2004).
Following the widespread performance of DC in many
centers worldwide, newer concerns have been raised.
There is still controversy on optimal timing of the proced-
ure, the effectiveness of the operation in different age
groups, and most importantly, the significant increase in
the severely disabled population of patients who have been
added to the survival (Chen et al. 2007; Foerch et al. 2004;
Jüttler et al. 2011; Jüttler et al. 2007). Such increase leads
to significant health burden and economic pressure over
families and the whole society. Until these controversies
have not been resolved, the application of DC may be a
challenge for every individual patient.s is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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data in two groups of patients subject to DC or aggressive
medical therapy, in population of patients from referral
center of Southern Iran with cerebral infarction.
Methods
We performed a prospective case–control study on pa-
tients with massive cerebral infarction of the MCA terri-
tory who were admitted consecutivelyto a tertiary center
affiliated to Shiraz University of Medical Sciences during
2010 and 2011. Institutional review board and research
ethics committee of the Shiraz University of Medical
Sciences evaluated and approved the work.
Patient selection
All consecutive patients with acute presentation of neuro-
logic symptoms, 80 years old or younger, who showed uni-
lateral infarctions of >50% MCA territory in brain CT or
MRI during the mentioned period of time were included
in the study. Indications for surgery included significant
midline shift (>5 mm), effacement of basal cisterns and
sulci, and the absence of brain herniation. Absent brain
stem reflexes was also a contraindication to enrollment.
All patients had to be admitted before 48 hours of presen-
tation. Patients with bilateral infarctions, hemorrhagic in-
farctions or transformations, and any terminal illness or
concomitant severe medical disease contraindicating sur-
gery were excluded. Early coma was not a contraindication
to enrollment.
A control group included also consecutive patients who
were admitted shortly before the routine application of DC
in our center. These patients, fulfilled the above-mentioned
criteria of study enrollment, but did not undergo surgery.
They had received aggressive medical treatment, and were
compared with patients from the case group.
Treatment
All patients in the control group received aggressive
standard medical treatment of cerebral infarction. This
treatment included admission to the neurocritical care
units, optimization of blood pressure, hyperosmolar ther-
apy, and mechanical ventilation and sedation if necessary.
In case of deterioration, no surgical management had been
considered for the patients.
All patients in the case group received aggressive
medical treatment, as outlined above, in the first step.
Surgery was planned after “significant deterioration”
and not prophylactically. “Significant deterioration”
was defined as further decrease in consciousness to
somnolence, stupor or early coma, or progressive develop-
ment of either unilateral or bilateral pupil abnormalities.
As stated earlier, patients with fixed neurological deficits
and deep long-standing coma were excluded from the
study.The operation consisted of a large fronto-temporo-
parietal craniectomy associated with subtemporal skull
decompression. We used a supine position using a roll
under the ipsilateral shoulder to avoid over rotation of
the head and jugular venous compression. The head was
positioned about 10 cm above heart level. We rotated a
large traumatic fronto-temporo-parietal skin flap. Five to
6 burr holes were made to design a single bone flap
measuring an average of 15 cm in larger diameter. We
ensured adequate subtemporal skull decompression to
prevent uncal herniation, and remained about 2 cm lat-
eral to the superior sagittal sinus. We opened the dura
making a single big dural flap, with a minimum of 5 mm
away from bone edges. Duraplasty with pericranium or
temporalis fascia was performed. Free bone flap was
saved in abdominal subcutaneous space. A subcutaneous
drain was inserted and kept until 24 hours after surgery.
Aggressive medical management was continued post-
operatively in neurocritical care unit. ICP monitoring was
not routinely used after surgery. A post-operative CT was
performed to rule-out hematoma formation, and ensure
adequate decompression. Patients were discharged after
becoming neurologically stable, occurring at least one
week after surgery.
Patient evaluation and follow-up
Clinical status was evaluated using GCS scores at presen-
tation. Demographic variables, pre-existing medical condi-
tions and details of neurological examination and imaging
were all recorded for further analysis. In-hospital compli-
cations, especially those related to the surgical procedure,
were all recorded. All patients were followed by both the
neurologist and neurosurgeon at three months after dis-
charge. When direct patient visit was not possible, we
tried to contact the patient or the visitors by phone to rec-
ord outcome. Outcome data included Glasgow outcome
scale (GOS) score and modified Rankin scale (MRS) at
three months after discharge. GOS is used routinely in
our center; however, for better clarification of the func-
tional abilities of patients especially with GOS scores of 3
and 4, we added the MRS scale, which gives more differ-
entiating data about the functional status of the patients
(Quinn et al. 2009).
Statistical analysis
All data were analyzed using SPSS software version 16.0.
Chi-square, one-way ANOVA and Mann–Whitney tests
were used to analyze the data.
Results
Patient characteristics
From 83 patients with malignant MCA infarction, 60 pa-
tients were considered eligible for inclusion into the
study; 30 patients in either case or control groups. Mean
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both groups. Male to female ration was 0.82. Basic pre-
operative clinical parameters have been presented in
Table 1. Statistical analysis shows that there was no sig-
nificant difference between the two groups; therefore,
the groups seem matched and comparable.
GCS score on admission was assessed using both para-
metric and non-parametric tests. Mean GCSs was 6.4
(range 4–12); and there was no significant difference be-
tween two groups (p = 0.29).
When assessing lateralization, 39 patients (65%) had
infarctions at the right MCA territory; while 21 (35%)
patients developed infarctions at the left side. There was
again no significant difference between case and control
groups (p = 0.65).
In the case group, 18 patients (60%) underwent surgery
within 24 hours after presentation; while the remaining
40% underwent surgery in the first 48 hours. Therefore,
there was no delayed surgery.
Outcome data
Table 2 shows a summary of outcome data in both groups.
Six patients (20%) died in the DC group, as compared to
20 patients (67%) who died in the control group. Such a
difference proved to be significant (p < 0.001).
GOS scores at three months follow-up were significantly
higher (mean: 2.9 vs. 1.5 in case vs. control groups; respec-
tively; p = 0.001). When using non-parametric Mann–
Whitney test, comparison of ranks proved also signifi-
cantly different (p = 0.001). Figure 1 shows the distribution
of different scores in each group.
MRS scale was also available for all patients, and simi-
larly, a significant difference was noted. Mean MRS was
3.3 in the case and 5.3 in the control groups (p < 0.001).
Nonparametric analysis also showed such a significant
result (p < 0.001). Figure 2 shows the distribution of dif-
ferent scores in each group.
The most common complication encountered during
hospital stay was deep venous thrombosis, which occurred
in 8.3% of patients, with no significant difference in any of
the groups. While all patients received low dose heparin
or enoxaparine as a prophylaxis, these two patients under-
went vena caval filter placement. Two patients also devel-
oped wound infectionsand underwent irrigation and
debridement of the wound and received IV antibiotics.Table 1 A summary of demographic, clinical and radiological
Study group Case (surgical)
Number of patients 30
Mean age ± SD (years) 59.0 ± 13.5
Sex (male-female) 11 – 19
Mean GCSs on admission 6.9
Laterality (right – left) 18 – 12Further analysis could not show any significant differ-
ence in outcome when assessing age, sex, laterality and
complication rate.
Discussion
Decompressive surgery has not been previously consid-
ered an option in management of patients with malig-
nant MCA infarction. After the introduction of this
treatment and its beneficial effects on the prognosis of
patients with malignant brain swelling after severe head
injury, this treatment has been also introduced for ische-
mic cerebral strokes (Aarabi et al. 2006; Spagnuolo et al.
2004). The rate of performance of DC has increased tre-
mendously in CVA patients following reports on the
beneficial effects of this treatment (Raffelsieper et al.
2002; Swiat et al. 2010; Walcott et al. 2011).
The surgical management of patients with malignant
MCA infarction remains a challenge. Even after decades,
there is no definitive agreement between experts about
the question of whether decompressive surgery should
be performed in patients with malignant MCA infarction
(Schwab et al. 1998). Decompressive hemicraniectomy
can relieve the mass effect due to infarcted brain tissue
and prevent brain herniation and death. Several studies
have shown that decompressive surgery can reduce the
mortality rate from 80 to 30% (Delgado-López et al.
2004; Kakuk et al. 2002; Mellado et al. 2005; Mori et al.
2001; Raffelsieper et al. 2002; Robertson et al. 2004;
Swiat et al. 2010; Ziai et al. 2003). There is a significant
number of studies in literature with controversial results
(Arac et al. 2009; Chen et al. 2007; Foerch et al. 2004;
Jüttler et al. 2011; Jüttler et al. 2007). Therefore in this
study, we compared the surgical versus non-surgical
management of patients with malignant MCA infarc-
tions. There are some important technical points which
warrant discussion. The size of the bone flap (Aarabi
et al. 2006) must be large enough to allow adequate de-
compression and prevent pressure at the edges. We con-
sidered an average size of 15 cm for the larger diameter
of the flap, and visualized no incarceration of the brain
tissue at the edges. We also designed a large duraplasty
using a single large flap, extending to an average of
5 mm from bone edges. Subtemporal skull decompres-
sion was also performed adequately to prevent uncal
herniation.parameters in study groups
Control (medical) Total p value
30 60
62.1 ± 11.0 60.6 ± 12.3 0.44
16 – 14 27 - 33 0.15
6.0 6.4 0.29
21 - 9 39 - 21 0.65
Table 2 Analysis of outcome data in the study groups
Study group Case (surgical) Control (medical) Total p value
Number of patients 30 30 60
Outcome in GCS scale 2.7 ± 1.2 1.5 ± 0.9 2.1 ± 1.2 0.001
Outcome in MRS scale 3.3 ± 1.9 5.3 ± 1.3 4.3 ± 1.9 <0.001
Mortality 20% 67% 43% <0.001
Complications - - - 0.34
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showing significant reduction (47%) in the surgically-
treated group. The mortality rate was 20% in DC group ver-
sus 67% in medically-treated group. This is comparable to
many other studies which have uniformly showed a reduc-
tion in mortality. Early decompressive hemicraniectomy in
patients with malignant MCA infarction reduced the mor-
tality rate by 50% at 1 year compared with best medical
treatment in one study (Molina & Selim 2011). Early
decompressive craniectomy has decreased mortality to
10-12% in some reports as compared with nonsurgical
management with over 50% mortality (Kiphuth et al. 2010;
Mellado et al. 2005; Staykov & Gupta 2011; Yang et al.
2005).Our results support previous findings that survival
may be better after surgery.
The main challenge is whether the survived patients
can return to normal functional life. Some reports have
questioned the benefits of decompressive surgery on
long-term survival and functional outcome, especially in
older patients. Quality of life after hemicraniectomy is
one of the most important factors in the choice of treat-
ment for malignant MCA infarction (Cho et al. 2003;
Kiphuth et al. 2010; Walz et al. 2002). Some neurosur-
geons do not prefer to treat malignant MCA infarction
surgically because of concerns about the post-operative
quality of life (Weil et al. 2011). There is a lot of contro-
versy in this issue. While some studies have shown that
nearly half of patients had good outcome after surgery
with GOS scores of 4 and 5 (Mattos et al. 2010; Mori et al.
2004), some others have reported that surgery could not12
9
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Case Group
Figure 1 Outcome at 3 months follow-up based on GOS scale.achieve significant good results (Staykov & Gupta 2011;
van der Worp & Kappelle 2011). This will increase the
number of severely disabled patients, imposing significant
pressure over the family and the whole society (Hofmeijer
et al. 2009; Schneck & Origitano 2006).
Analysis of our data showed that near 30% of patients
in the surgical group had good outcome, i.e. GOS scores
of 4 and 5; however, respective rate was only 3.3% in the
nonsurgical group. Also, 40% of patients in the DC
group and 83% in the control group developed poor out-
come (GOS scores of 1 and 2). This means that DC not
only decreased mortality but also improved outcome.
Review of literature shows that early surgery (during
24 hours from onset of stroke) has had very good result
in all ages especially in younger patients (Koh et al.
2000; Pillai et al. 2007); while surgery later than 48
hours may not benefit patients (Antuña-Ramos et al.
2009; Cho et al. 2003; Chen et al. 2007; Hernández-
Medrano et al. 2012; Hofmeijer et al. 2009; Khatri et al.
2008; Schwab et al. 1998; Vahedi et al. 2007; Zhao et al.
2012). We also operated our patients at an early stage
(earlier than 48 hours), and therefore, the observed ef-
ficacy of DC in our series is perhaps due to this early
intervention.
Age is also another influencing factor. Some studies have
shown that patients older than 60 had MRS scores of 4 and
greater; while patients younger than 60 showed MRS scores
of 3 or lower following decompressive hemicraniectomy
(Chen et al. 2007; Foerch et al. 2004; Vahedi et al. 2007;
Yang et al. 2005). In this study, we did not include patients25
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GOS 3
GOS 1-2
91
12
4
9
25
Case Group Control Group
MRS 5-6
MRS 3-4
MRS 0-2
Figure 2 Outcome at three months follow-up based on MRS scale.
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tween the age groups.
The only problem remains in patients with GOS
scores of 3 (MRS of 3 and 4), namely severely disabled
patients, which were more frequent in the surgical group
(30% versus 13%; respectively). This means that although
surgery improved the whole outcome significantly (an
average of 1 scores on the GOS and 2 scores on MRS
scales) and decreased mortality, survived patients are
still in high risk to be severely disabled. Whether this
survival is of any benefit to the patients’ families or the
whole society is a controversy (Carandang & Krieger
2008; Holtkamp et al. 2001; Kiphuth et al. 2010; Weil
et al. 2011). This problem may be considered as a cost-
effectiveness issue by health policy makers, or may be pre-
sented to the family of any individual patient for decision
making. One family may consider even a 1% chance of
survival very valuable, while the other one may not accept
the continuous expensive care of a severely disabled pa-
tient with nearly any chance of improvement. Therefore,
consideration of surgical treatment for every patient re-
quires careful consultation with the family members
(Hofmeijer et al. 2009; Schneck & Origitano 2006).
A major limitation of the study is the lack of ran-
domization and control of samples. The previously-
published beneficial data on effectiveness of DC on
mortality (Delgado-López et al. 2004; Kakuk et al. 2002;
Mellado et al. 2005; Mori et al. 2001; Raffelsieper et al.
2002; Robertson et al. 2004; Swiat et al. 2010; Ziai et al.
2003) have made the performance of randomized trials
impossible. Our data may provide at most level 2 evi-
dence on the benefits of DC; while longer follow-ups
may yield more beneficial data.
Conclusion
Early DC, performed within 48 hours after presentation
and on patients younger than 80, could reduce mortality
and improve outcome significantly in unilateral malig-
nant MCA infarction. We recommend performing theprocedure for every eligible patient after careful consult-
ation with the family members.
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